2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Abstract

Description

Keywords

Guidelines, acute cardiac care, acute coronary syndrome, angioplasty, anticoagulation, antiplatelet, apixaban, aspirin, atherothrombosis, betablockers, bleedings, bivalirudin, bypass surgery, cangrelor, chest pain unit, clopidogrel, dabigatran, diabetes, dual antithrombotic therapy, early invasive strategy, edoxaban, enoxaparin, European Society of Cardiology, fondaparinux, glycoprotein IIb/IIIa inhibitors, heparin, high-sensitivity troponin, minoca, myocardial ischaemia, myocardial infarction, nitrates, non-ST-elevation myocardial infarction, platelet inhibition, prasugrel, recommendations, revascularization, rhythm monitoring, rivaroxaban, stent, ticagrelor, triple therapy, unstable angina, 3.2 Clinical medicine, 1.1. Scientific article indexed in Web of Science and/or Scopus database, SDG 3 - Good Health and Well-being

Citation

Collet, J-P, Thiele, H, ESC Scientific Document Group & Maca, A 2021, '2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation', European Heart Journal, vol. 42, no. 14, pp. 1289-1367. https://doi.org/10.1093/eurheartj/ehaa575